Author(s) :

Rida sarwar, Alishbah Roobi, Noreen Aslam, Hina Pervaiz .

Volume/Issue :

Abstract :

Multiple sclerosis (MS) is a central nervous system neurodegenerative and autoimmune demyelinating disease that is the main cause of nontraumatic neurological impairment in young adults. Worldwide, the prevalence of MS is rising, as are the disease's socioeconomic consequences. Diseases such as childhood obesity, smoking, poor vitamin D levels, and Epstein-Barr virus infection are linked with an increased risk of developing multiple sclerosis, according to the epidemiology of the disease. A multimodal strategy is required to treat, manage, and successfully control acute attacks and progressing illness. Many people now have a better long-term outlook thanks to advancements in treatment for all types of MS, particularly relapse MS. In order to recognize the crucial role B cells play in pathogenesis, our understanding of MS immunological pathology is still evolving from a mostly T-cell-mediated perspective. Higher-efficacy drugs are now advised for adherence and tolerance in individuals with early disease since physicians are using them as first-line treatments before irreversible harm is evident.

No. of Downloads :

1